JY-201

N/A

Report date: 2024/02/05 14:05:14

Base Information

Drug NameJY-201

Drug Alias NameP-BsAb-ADCPegylated biparatopic antibody-drug conjugatePegylated BsAb-ADCJY201JY-201

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC) > Linker > Cleavable linkerBiologics > Protein drugs > Immunoglobulin > Antibody > Antibody conjugate > Antibody drug conjugate (ADC)

Mechanisms of ActionAnti-HER2Mitosis inhibitorsTubulin polymerisation inhibitors

TargetsReceptor protein-tyrosine kinase erbB-2Tubulin

Therapy Area/IndicationsSolid tumours

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryMainland China

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaPreclinical

Originator CompaniesShenzhen Enduring Biotech Ltd

China Registration ClassN/A

Develop Information

Active CompaniesShenzhen Enduring Biotech Ltd

Inactive CompaniesN/A

Active IndicationsSolid tumours

Inactive IndicationsN/A

Other Information

ATC CodeN/A